COMPARATIVE EFFECTIVENESS OF DUAL ANTIPLATELET THERAPY VERSUS MONOTHERAPY IN PATIENTS WITH ISCHEMIC STROKE
Keywords:
ischemic stroke, dual antiplatelet therapy, monoantiplatelet monotherapy, good outcome, poor outcomeAbstract
This article highlights the difference between efficiency of dual antiplatelet therapy and antiplatelet monotherapy in 60 patients with ischemic stroke.
References
Musaev, S., Musaeva, Y., & Rakhimbaeva, G. (2024). Neuroinflammatory mechanisms in hemorrhagic stroke: focus on the background. Journal of education and scientific medicine, 1(2), 49-58.
Rakhimbaeva GS, Abdurakhmonova KBK. ICAM-1 and CRP as biomarkers of 3-month outcome in acute ischaemic stroke. BMJ Neurol Open. 2023 Dec 20;5(2):e000516. doi: 10.1136/bmjno-2023-000516. PMID: 38145240; PMCID: PMC10749038.
Brown DL, Levine DA, Albright K, Kapral MK, Leung LY, Reeves MJ, et al. Benefits and Risks of Dual Versus Single Antiplatelet Therapy for Secondary Stroke Prevention. Stroke 2021; 52: e468-e479.
Del Giovane C, Boncoraglio GB, Bertù L, Banzi R, Tramacere I. Antiplatelet drugs for secondary prevention in patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis. BMC Neurol 2021; 21: 1-10.
Dong J, Wang F, Sundararajan S. Use of Dual Antiplatelet Therapy following Ischemic Stroke. Stroke 2020; 51: e78-e80.
Edward CJ. Ischemic stroke [Internet]. Medical Crossfire. 2022 [cited 2023 May26. Available from: https://emedicine. medscape.com/article/1916852-overview
Franziska H, Fred R. Management of Acute Ischemic Stroke. Concise Defin Rev 2020; 48: 1654-1663.
Jourdi G, Godier A, Lordkipanidzé M, Marquis-Gravel G, Gaussem P. Antiplatelet Therapy for Atherothrombotic Disease in 2022—From Population to Patient-Centered Approaches. Front Cardiovasc Med 2022; 9: 1-19.
Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D, et al. 2021 Guideline for the prevention of stroke in patients with stroke and transient ischemic attack; A guideline from the American Heart Association/American Stroke Association. Stroke 2021; 52: e364–e467.
Minhas JS, Chithiramohan T, Wang X, Barnes SC, Clough RH, Kadicheeni M, et al. Oral antiplatelet therapy for acute ischaemic stroke (Review). Cochrane Database Syst Rev 2022; 1: 1–16.
Pace WD, Earl A, Bryant C. Antiplatelet Therapy for Secondary Prevention of Ischemic Stroke. Cardiovascular 2020; 45: HS8-HS12.
Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2019; 50: e344–e418.
Stahmeyer JT, Stubenrauch S, Geyer S, Weissenborn K, Eberhard S. The Frequency and Timing of Recurrent Stroke. Dtsch Arztebl Int 2019; 116: 711-717.
Tadi Prasanna FL. Acute Stroke. [Updated 2023 Feb 28]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan [Internet]. 2023 [cited 2023 May 26]. p. 88-100.
Yiping C, Neil W, Yu G, Iain T, Christiana K, Ling Y, et al. Mortality and recurrent vascular events after first incident stroke: a 9-year community-based study of 0·5 million Chinese adults. Lancet Glob Heal 2020; 8: e580-e590.
Abdurakhmonova K.B., PhD researcher
E-mail: doctorabdurakhmonova@gmail.com
Tel.: mobile: + 998 97 357-99-00
